Literature DB >> 12734039

The changing face of esophageal malignancy.

Timothy R Koch1.   

Abstract

Concern has been expressed about the rapid increase in the incidence of esophageal carcinoma in the United States. This rise is due to an increase in the number of cases of adenocarcinoma of the esophagus. Because of the relatively small number of cases of esophageal carcinoma, the absolute risk of developing this cancer in the United States remains small. Potential origins for this increase in esophageal adenocarcinoma are examined in this review, including the risk induced by obesity, low dietary antioxidants, high dietary fat, family history of breast cancer, smoking, gastroesophageal reflux, and Barrett's esophagus. The risk of esophageal adenocarcinoma is inversely associated with infection by Helicobacter pylori organisms. A better understanding of risk factors involved in the increased incidence of esophageal adenocarcinoma is important for development of new preventive strategies for this serious disorder.

Entities:  

Mesh:

Year:  2003        PMID: 12734039     DOI: 10.1007/s11894-003-0018-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  27 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

2.  Dietary patterns and adenocarcinoma of the esophagus and distal stomach.

Authors:  Honglei Chen; Mary H Ward; Barry I Graubard; Ellen F Heineman; Rodney M Markin; Nancy A Potischman; Robert M Russell; Dennis D Weisenburger; Katherine L Tucker
Journal:  Am J Clin Nutr       Date:  2002-01       Impact factor: 7.045

Review 3.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

4.  Family history of cancer and risk of esophageal and gastric cancers in the United States.

Authors:  P K Dhillon; D C Farrow; T L Vaughan; W H Chow; H A Risch; M D Gammon; S T Mayne; J L Stanford; J B Schoenberg; H Ahsan; R Dubrow; A B West; H Rotterdam; W J Blot; J F Fraumeni
Journal:  Int J Cancer       Date:  2001-07-01       Impact factor: 7.396

5.  Changing pattern of esophageal cancer incidence in New Mexico.

Authors:  K J Vega; M M Jamal
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

6.  Nutrient intake and risk of subtypes of esophageal and gastric cancer.

Authors:  S T Mayne; H A Risch; R Dubrow; W H Chow; M D Gammon; T L Vaughan; D C Farrow; J B Schoenberg; J L Stanford; H Ahsan; A B West; H Rotterdam; W J Blot; J F Fraumeni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

7.  Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.

Authors:  C Walther; T Zilling; R Perfekt; T Möller
Journal:  Eur J Surg       Date:  2001-10

8.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Authors:  Douglas A Corley; Theodore R Levin; Laurel A Habel; Noel S Weiss; Patricia A Buffler
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

9.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

10.  Treatment outcomes of resected esophageal cancer.

Authors:  Wayne Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko R Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  2 in total

1.  Risk assessment of esophageal adenocarcinoma using γ-H2AX assay.

Authors:  Enping Xu; Yilei Gong; Jian Gu; Lin Jie; Jaffer A Ajani; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-31       Impact factor: 4.254

Review 2.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.